These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37732499)

  • 1. Characteristics of mild and severe apalutamide-related cutaneous adverse events in patients with prostate cancer: A review of the literature.
    Katsuta M; Nobeyama Y; Hirafuku K; Tashiro K; Kimura T; Asahina A
    J Dermatol; 2024 Jan; 51(1):110-114. PubMed ID: 37732499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Cutaneous Drug Reactions: Do Overlapping Forms Exist?
    Horcajada-Reales C; Pulido-Pérez A; Suárez-Fernández R
    Actas Dermosifiliogr; 2016; 107(1):23-33. PubMed ID: 26520037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maculopapular Drug Eruption Caused by Apalutamide: Case Report and Review of the Literature.
    Katayama H; Saeki H; Osada SI
    J Nippon Med Sch; 2022 Nov; 89(5):550-554. PubMed ID: 34526471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
    Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
    J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: Apalutamide-induced severe lethal cutaneous adverse effects in China.
    Wang Q; Cao H; Zhang X; Wu H; Tang Z
    Front Immunol; 2023; 14():1291564. PubMed ID: 38274795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
    Owen CE; Jones JM
    Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis during apalutamide treatment in a patient with prostate cancer.
    Honda T; Tohi Y; Kaku Y; Kimura N; Kato T; Haba R; Dainichi T; Sugimoto M
    IJU Case Rep; 2022 Nov; 5(6):497-500. PubMed ID: 36341202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
    Hadavand MA; Kaffenberger B; Cartron AM; Trinidad JCL
    J Am Acad Dermatol; 2022 Sep; 87(3):632-639. PubMed ID: 32926975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of cutaneous adverse drug reactions].
    Ingen-Housz-Oro S
    Rev Prat; 2023 Mar; 73(3):307-313. PubMed ID: 37289124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe adverse drug reactions.
    Teo YX; Walsh SA
    Clin Med (Lond); 2016 Feb; 16(1):79-83. PubMed ID: 26833523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse cutaneous drug eruptions: current understanding.
    Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for Severe Cutaneous Adverse Reactions.
    Cho YT; Chu CY
    J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognostic factors of severe cutaneous adverse drug reactions: A single-center retrospective study of 209 cases in China.
    Deng M; Su Y; Wu R; Li S; Tang G; Kuang Q; Luo X; Zhu Y; Shen W
    Int Immunopharmacol; 2023 Jan; 114():109530. PubMed ID: 36508915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
    Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
    Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute generalized exanthematous pustulosis with blistering mimicking toxic epidermal necrolysis, associated with a primary mumps infection.
    Azib S; Florin V; Fourrier F; Delaporte E; Staumont-Sallé D
    Clin Exp Dermatol; 2014 Aug; 39(6):723-5. PubMed ID: 24986490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The major SCAR syndromes].
    Piérard GE; Lesuisse M; Piérard-Franchimont C
    Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apalutamide-Induced Toxic Epidermal Necrolysis in a Caucasian Patient with Metastatic Castration-Sensitive Prostate Cancer: A Case Report and Review of the Literature.
    Flynn CR; Liu SC; Byrne B; Ralph J; Paz G; Anwar S; Buchalter J; Fitzpatrick OM; Markham T; Donnellan P
    Case Rep Oncol; 2023; 16(1):652-661. PubMed ID: 37900799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
    Tee CT; Abdullah NH; Kristummoonthy P; Lee CS
    Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.
    Guvenir H; Arikoglu T; Vezir E; Misirlioglu ED
    Curr Pharm Des; 2019; 25(36):3840-3854. PubMed ID: 31696807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.